Robert J. Greczyn Jr - May 31, 2020 Form 4 Insider Report for TIVITY HEALTH, INC. (TVTY)

Role: Director
Signature: /s/ Joseph Raymond Bilbao by power of attorney for Robert J. Greczyn, Jr.
Stock symbol: TVTY
Transactions as of: May 31, 2020
Transactions value $: -$2,774,590
Form type: 4
Date filed: 6/29/2022, 04:55 PM
Next filing: May 21, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVTY	Common Stock	Disposed to Issuer	$0	-7.83K	-8.4%	$0.00	85.4K	May 31, 2020	Direct	F1
transaction	TVTY	Common Stock	Disposed to Issuer	-$2.77M	-85.4K	-100%	$32.50	0	Jun 28, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Robert J. Greczyn Jr is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Reflects restricted stock units forfeited upon the termination of the reporting person's employment as Interim Chief Executive Officer of the issuer on May 31, 2020
F2	Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.

Content

Reflects restricted stock units forfeited upon the termination of the reporting person's employment as Interim Chief Executive Officer of the issuer on May 31, 2020

Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.